流行病对医疗保健使用和患者成年人死亡的影响:人口研究
Maria Espinoza Vargas1, Andrea S Gershon2,3,4,5, Michael Pugliese1,2
1The Ottawa Hospital Research Institute, Ottawa, ON, Canada.
概括
由于COVID-19大流行,成年患者的医疗保健机会减少,导致死亡率增加. 诊断测试频率与死亡率有关,突显了持续获得护理的必要性.
科学领域:
- 神经学 神经学
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 在全球范围内,COVID-19大流行严重扰乱了医疗保健服务.
- 患有的成年人在获得一致的医疗护理方面面临着独特的挑战.
- 了解与流行病相关的医疗保健利用变化对于弱势群体至关重要.
研究的目的:
- 在COVID-19流行病的第一年分析患者成年人医疗保健利用率和死亡率趋势.
- 评估减少门诊访问,诊断测试和不良健康结果 (住院治疗,急诊,死亡) 之间的关联.
主要方法:
- 使用安大略省卫生行政数据进行基于人口的研究 (2020年3月至2021年3月与2016年至2019年相比).
- 时间序列分析 (自回归集成移动平均模型) 来预测月率.
- 准森模型用于检查医疗保健和死亡率之间的相互作用.
主要成果:
- 在流行病早期观察到的门诊访问,诊断测试,急诊室访问和住院的减少.
- 在最初的流行病阶段,所有原因的死亡率暂时增加.
- 较高的死亡率与较低的诊断测试频率相关,表明有显著的相互作用 (p <.0001).
结论:
- 疫情最初减少了成年患者获得医疗保健的机会,随后死亡率上升.
- 保持对诊断测试的准入对于治疗和预防不良事件至关重要.
- 对非紧急医疗服务的限制需要在病护理的流行病规划中仔细考虑.
相关概念视频
Arteries of the Lower Limbs
191
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
191
Antiepileptic Drugs: Potassium Channel Activators
184
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
184
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
307
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
307
Seizures: Classification
369
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
369
Antiepileptic Drugs: Sodium Channel Blockers
581
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
581
Antiepileptic Drugs: Calcium Channel Blockers
410
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
410


